Niaid preclinical development support - performance of toxicity testing for HIV proteins
Ended Awarded Last action
- Contract number
- HHSN27200028
- Awardee
-
Advanced Bioscience Laboratories, Inc. UEI MK4QC9EKZXG8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $322,862
Award facts
- Contract value 100% obligated
- $322,862.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Change Order | $69,991 | |
| Original award | $252,871 |
About this award
This federal contract was awarded to Advanced Bioscience Laboratories, Inc. (ABL) by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services (HHS). The contract, with a ceiling value of $322,862.00, is for the performance of toxicity testing for HIV proteins as part of NIAID's Preclinical Development Support program. The contract has no set-aside designation. ABL, a leading contract research and manufacturing organization, has been awarded multiple Indefinite Delivery Vehicles (IDVs) from federal agencies such as NIAID, the National Institute of Neurological Disorders and Stroke (NINDS), and the National Cancer Institute (NCI) to support the development of vaccines, therapeutics, and diagnostics across various disease areas. This contract is one of the many federal awards ABL has received to advance the development of medical countermeasures for infectious diseases and other health conditions.
Quick answers
Who was awarded contract HHSN27200028?
HHSN27200028 was awarded to Advanced Bioscience Laboratories, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on April 15, 2016.
How much is contract HHSN27200028 worth?
The government has obligated $322,862 on HHSN27200028.
Is contract HHSN27200028 an order under another contract?
Yes. HHSN27200028 is a delivery order under HHSN272201100021I, an indefinite delivery contract.
Was contract HHSN27200028 competed?
The extent of competition for HHSN27200028 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award